Angelino Antonio, Khanh Do Ta, An Ha Nguyen, Pham Tuan
Department of Economics and Management, University of Ferrara, Via Voltapaletto 11, 44121 Ferrara FE, Italy.
Vietnam Academy of Social Sciences, 1 Liễu Giai, Ba Đình, Hà Nội 119-405, Vietnam.
Int J Environ Res Public Health. 2017 Aug 29;14(9):976. doi: 10.3390/ijerph14090976.
Vietnam is a fast growing economy in the Asian region with a significantly high population (over 92 million in 2015). Although still expanding (about 1.1% on average during 2000-2015), the Vietnamese population is considered to be entering the ageing stage at a very high rate. The rapid expansion of the middle-income urban class and the ageing people ratio have dramatically pushed up the demand for healthcare goods, particularly in terms of pharmaceutical products. Since the early 1990s the government has addressed the necessities of rising demand for healthcare products by formulating a series of policies aimed at promoting the development of the pharmaceutical industry. However, the implementation of such policies does not seem to have been completely efficient given that the country still needs to import up to 90% of its pharmaceutical consumption. This paper aims to explore the development of the pharmaceutical industry during the years 1990-2015 and to identify a series of weaknesses in the government promotion of the industry. Future developments will also be discussed on how the Vietnamese pharmaceutical industry could increase its participation in the regional supply chain, which is currently being dominated by big players like India and China.
越南是亚洲地区经济快速增长的国家，人口众多（2015年超过9200万）。尽管越南人口仍在增长（2000 - 2015年期间平均增长率约为1.1%），但其人口正以非常高的速度进入老龄化阶段。中等收入城市阶层的迅速扩大以及老龄化人口比例的上升极大地推动了医疗保健产品的需求，尤其是药品方面的需求。自20世纪90年代初以来，政府通过制定一系列旨在促进制药行业发展的政策来满足对医疗保健产品不断增长的需求。然而，鉴于该国仍需进口高达90%的药品消费量，这些政策的实施似乎并不完全有效。本文旨在探讨1990 - 2015年期间制药行业的发展情况，并找出政府在推动该行业发展方面存在的一系列弱点。还将讨论越南制药行业如何增加其在区域供应链中的参与度的未来发展情况，目前该区域供应链由印度和中国等大国主导。
